RY

163.65

+2.96%↑

TD

94.34

+3.07%↑

BMO

137.63

+3.93%↑

CM

96.33

+4.25%↑

BNS

70.18

+3.3%↑

RY

163.65

+2.96%↑

TD

94.34

+3.07%↑

BMO

137.63

+3.93%↑

CM

96.33

+4.25%↑

BNS

70.18

+3.3%↑

RY

163.65

+2.96%↑

TD

94.34

+3.07%↑

BMO

137.63

+3.93%↑

CM

96.33

+4.25%↑

BNS

70.18

+3.3%↑

RY

163.65

+2.96%↑

TD

94.34

+3.07%↑

BMO

137.63

+3.93%↑

CM

96.33

+4.25%↑

BNS

70.18

+3.3%↑

RY

163.65

+2.96%↑

TD

94.34

+3.07%↑

BMO

137.63

+3.93%↑

CM

96.33

+4.25%↑

BNS

70.18

+3.3%↑

Search

Kinsale Capital Group Inc

Atidarymo kaina

SektoriusFinansų sektorius

343.02 2

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

333.69

Max

343.01

Pagrindiniai rodikliai

By Trading Economics

Pajamos

362M

504M

Pardavimai

-14M

483M

P/E

Sektoriaus vid.

15.152

54.484

Pelnas, tenkantis vienai akcijai

5.81

Dividendų pajamingumas

0.21

Pelno marža

104.209

Darbuotojai

711

EBITDA

2.2M

184M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+15.07% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.21%

4.92%

Kitas uždarbis

2026-04-23

Kitas dividendų mokėjimo data

2026-06-11

Kita Ex Dividend data

2026-05-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.5B

7.6B

Ankstesnė atidarymo kaina

341.02

Ankstesnė uždarymo kaina

343.02

Naujienos nuotaikos

By Acuity

23%

77%

56 / 441 reitingas Finance

Kinsale Capital Group Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-31 23:31; UTC

Karštos akcijos

Stocks to Watch: Nike, RH, NCino

2026-03-31 22:35; UTC

Uždarbis

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

2026-04-01 00:00; UTC

Įsigijimai, susijungimai, perėmimai

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

2026-03-31 23:50; UTC

Įsigijimai, susijungimai, perėmimai

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

2026-03-31 23:43; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

2026-03-31 23:33; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

2026-03-31 23:21; UTC

Uždarbis

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

2026-03-31 23:14; UTC

Rinkos pokalbiai
Uždarbis

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

2026-03-31 23:12; UTC

Rinkos pokalbiai

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

2026-03-31 22:36; UTC

Uždarbis

China Vanke 2025 Loss Widens >000002.SZ

2026-03-31 22:36; UTC

Uždarbis

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

2026-03-31 22:36; UTC

Uždarbis

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

2026-03-31 22:36; UTC

Uždarbis

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

2026-03-31 22:36; UTC

Uždarbis

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

2026-03-31 21:46; UTC

Įsigijimai, susijungimai, perėmimai

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

2026-03-31 21:36; UTC

Rinkos pokalbiai

West African Resources's Costs Higher Than Bull Expected -- Market Talk

2026-03-31 21:35; UTC

Uždarbis

Nike Expects China Sales Down 20% in 4Q, CFO Says

2026-03-31 21:35; UTC

Uždarbis

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

2026-03-31 21:35; UTC

Uždarbis

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

2026-03-31 21:33; UTC

Įsigijimai, susijungimai, perėmimai

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

2026-03-31 21:33; UTC

Uždarbis

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

2026-03-31 21:32; UTC

Uždarbis

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

2026-03-31 21:28; UTC

Uždarbis

Nike Expects to End 4Q With Elevated Inventory, CFO Says

2026-03-31 21:26; UTC

Uždarbis

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

2026-03-31 21:25; UTC

Uždarbis

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

2026-03-31 21:24; UTC

Rinkos pokalbiai
Uždarbis

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

2026-03-31 21:22; UTC

Uždarbis

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

2026-03-31 21:22; UTC

Uždarbis

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

2026-03-31 21:21; UTC

Uždarbis

Nike's Digital Channel Still Too Promotional, CFO Says

2026-03-31 21:20; UTC

Uždarbis

Nike CEO: Converse Remains Important to Portfolio

Akcijų palyginimas

Kainos pokytis

Kinsale Capital Group Inc Prognozė

Kainos tikslas

By TipRanks

15.07% į viršų

12 mėnesių prognozė

Vidutinis 387.43 USD  15.07%

Aukščiausias 450 USD

Žemiausias 312 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Kinsale Capital Group Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

10 ratings

4

Pirkti

4

Laikyti

2

Parduoti

Rinkos nuotaikos

By Acuity

56 / 441 reitingas Finansų sektorius

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Kinsale Capital Group Inc

Kinsale Capital Group, Inc., a specialty insurance company, engages in the provision of property and casualty insurance products in the United States. The company's commercial lines offerings include commercial property, small business casualty and property, excess and general casualty, construction, allied health, life sciences, entertainment, energy, environmental, excess professional, health care, public entity, commercial auto, inland marine, aviation, ocean marine, product recall, and railroad, as well as product, professional, and management liability insurance. It markets and sells its insurance products in all 50 states, the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands primarily through a network of independent insurance brokers. The company was founded in 2009 and is headquartered in Richmond, Virginia.
help-icon Live chat